Takeda, a global leader in biopharmaceutical innovation, has announced the official opening of its Innovation Capability Center (ICC) in Bengaluru, a centre where digital solutions will be built as part of Takeda’s global digital transformation, which includes insourcing capabilities.

This marks Takeda’s first ICC in Asia, following successful establishments in Slovakia and Mexico. The ICC help support the company’s dedication to advancing healthcare through innovative solutions. These cutting-edge solutions will help advance operations and have an impact on Takeda’s workforce.

The company’s mission in India focuses on ensuring sustainable access to healthcare, bolstered by strategic partnerships. Takeda’s diverse therapeutic portfolio addresses gastrointestinal disorders, rare diseases, immunology, oncology and vaccines, underscoring its commitment to data-driven innovation and transforming treatments. 

The ICC in India will develop key technology capabilities to fuel innovation by embracing data and digital solutions using an agile, patient-centric and solution focused approach. The ICC will concentrate on pioneering advancements across domains including:

• Artificial Intelligence (AI) and GenAI to enhance efficiency and predictive analytics in healthcare
• Device Engineering and Application Virtualization to drive innovation in product development and patient-centric solutions
• Data Science and Visualization to enable data-driven decision-making for improved patient outcomes

Image caption- Left to right: Sanjay Patel, Global Head of Innovation Capability Solutions & Services, Takeda; Gabriele Ricci, Chief Data and Technology Officer at Takeda;  Tilak Banerjee, Head of Takeda ICC India inaugurating Takeda ICC India (Bengaluru)